Lumos Pharma
1 Article found

Lumos Pharma articles

Abstract
Abstract Title: “LUM-201 Elicits Greater GH Response than Standard GH Secretagogues in Pediatric Growth Hormone Deficiency “Presentation Type: Oral Science Type and Topic: Clinical Trial Introduction: LUM-201 (ibutamoren, formerly MK-0677) is an orally administered GH-secretagogue that stimulates the GH secretagogue receptor (GHSR1a) in the hypothalamus and pituitary. LUM-201 is in development for long-term use in a subset of PGHD patients with moder

Mar. 19, 2021

George Bright;Roy Smith;Michael O. Thorner